Alzheimer's Disease and Dementia
Our work in Alzheimer's Disease and Dementia
-
Alzheimer’s-Preventing Drugs May Already Exist – We Just Can’t Test Them
Many people who use statins to fight heart disease seem to be on a slower track for developing Alzheimer’s compared to the rest of the population. Yet multiple hurdles stand in the way for this sort of study.
Categorized in -
The Future of Cures: Investing in Value, Innovation and Access
High-cost drugs can generate even higher societal value when they combat serious disease, which should be accounted for in financing methods and pricing models to encourage medical innovation.
Categorized in -
Cholesterol-Fighting Drugs Lower Risk of Alzheimer’s Disease
The incidence of Alzheimer’s was reduced for beneficiaries frequently prescribed statins.
Categorized in -
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
High statin use is associated with lower incidence of Alzheimer disease.
-
Schaeffer Center Post-Doctoral Fellow Receives Alzheimer’s Greater Los Angeles Young Investigator Award
Barthold was selected for his research on Alzheimer’s disease (AD) and his potential to contribute significantly to the field in the future.
-
Competing Risks: Investing in Sickness Rather Than Health
The authors contend that the time has come for the US to distance itself from the rhetoric and colored ribbons of conquering individual diseases to begin a real discussion about how best to help Americans achieve longer, healthier, and more productive lives.
Categorized in -
The Economic Promise of Delayed Aging
Expanded biomedical research to delay aging appears to be a highly efficient way to forestall disease and extend a healthy life.
Categorized in -
The Value of Delaying Alzheimer’s Disease Onset
Models show that the number of patients will more than double in 40 years, and costs associated with their care will nearly quintuple.
Categorized in